U.S. markets open in 2 hours 56 minutes

Sarepta Therapeutics, Inc. (SRPT)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
118.59-2.63 (-2.17%)
At close: 04:00PM EDT
119.15 +0.56 (+0.47%)
After hours: 07:51PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close121.22
Bid0.00 x 800
Ask0.00 x 1300
Day's Range118.09 - 121.67
52 Week Range100.15 - 159.89
Avg. Volume904,341
Market Cap11.062B
Beta (5Y Monthly)0.94
PE Ratio (TTM)N/A
EPS (TTM)-10.07
Earnings DateOct 31, 2023 - Nov 06, 2023
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est180.94
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for SRPT

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Sarepta Therapeutics, Inc.
    Daily – Vickers Top Buyers & Sellers for 09/16/2022The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
    Fair Value
    Economic Moat
    last yearArgus Research
View more
  • Business Wire

    Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    CAMBRIDGE, Mass., September 29, 2023--Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, granted equity awards on September 29, 2023 that were previously approved by the Compensation Committee of its Board of Directors under Sarepta’s 2014 Employment Commencement Incentive Plan, as a material inducement to employment to 24 individuals hired by Sarepta in September 2023. The equity awards were approved in accordance with Nasdaq Listing Rule 5635(

  • Investor's Business Daily

    Have Million-Dollar Gene Therapies Finally Reached An Inflection Point?

    The big names behind biotech stocks no longer want to merely treat diseases, they want to cure them. But it's going to be costly.

  • Motley Fool

    2 Top Growth Stocks to Buy With $500

    Here are two companies to consider: Sarepta Therapeutics (NASDAQ: SRPT) and Shopify (NYSE: SHOP). Sarepta Therapeutics is a biotech company that focuses on developing medicines for rare diseases. Sarepta Therapeutics' portfolio of DMD therapies is generating consistently growing sales.